PharmaTimesOriginal article
Definium reports positive results for anxiety treatment
Phase 3positivePositive
AI Analysis
Summary
Definium announced positive Phase 3 results for its anxiety treatment, demonstrating strong efficacy. The study data supports advancement toward potential regulatory submission.
Clinical Trial Data
Phase
Phase 3
Primary Endpoint
Met
Outcome Details
Strong efficacy demonstrated
Importance:7/10
Sentiment:
0.75
Phase 3anxietypositive resultsefficacy
Read the original article
Published by PharmaTimes on August 18, 2026 12:54 PM